Therefore, pharmacological strategies to suppress the COX-2 expression and PGE2 secretion are of great interest and are being exploited to develop potent therapeutics to resolve inflammation and several pro-tumor conditions [51]–[56]. This evidence concerns the gene PTGS2 and neoplasm.